Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nuvation Bio, Inc.

2.49
+0.01000.40%
Volume:3.98M
Turnover:9.84M
Market Cap:845.55M
PE:-1.22
High:2.53
Open:2.52
Low:2.42
Close:2.48
Loading ...

Citizens JMP Reaffirms Their Buy Rating on Nuvation Bio (NUVB)

TIPRANKS
·
02 Jun

Nuvation Bio Inc. Conducted Annual Stockholders Meeting

Reuters
·
24 May

Nuvation Bio Inc. Awaits FDA Decision on Taletrectinib with PDUFA Date Set for June 23, 2025

Reuters
·
22 May

Nuvation Bio Price Target Maintained With a $5.00/Share by Wedbush

Dow Jones
·
16 May

Nuvation Bio Inc. to Present Key Data on Taletrectinib vs. Entrectinib at ISPOR 2025 Conference

Reuters
·
14 May

Nuvation Bio Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
08 May

Nuvation Bio Q1 EPS $(0.16), Inline, Sales $3.08M Beat $416.67K Estimate

Benzinga
·
08 May

BRIEF-Nuvation Bio Q1 EPS USD -0.16

Reuters
·
08 May

Nuvation Bio Inc expected to post a loss of 16 cents a share - Earnings Preview

Reuters
·
06 May

Nuvation Bio to Present at The Citizens Life Sciences Conference

Business Wire
·
02 May

Nuvation Bio Initiated at Market Outperform by JMP Securities

Dow Jones
·
23 Apr

Nuvation Bio to Report Results for First Quarter 2025 and Provide Business Update on May 7, 2025

THOMSON REUTERS
·
23 Apr

Nuvation Bio to Report Results for First Quarter 2025 and Provide Business Update on May 7, 2025

Business Wire
·
23 Apr

Is Nuvation Bio Inc. (NYSE:NUVB) the Best Biotech Penny Stock to Buy According to Hedge Funds?

Insider Monkey
·
16 Apr

Nuvation Bio Inc. (NUVB): Among Stocks Under $10 that Will Triple

Insider Monkey
·
09 Apr

Nuvation Bio to Present at the Jones Healthcare and Technology Innovation Conference

Business Wire
·
02 Apr

Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE) and Nuvation Bio (NUVB)

TIPRANKS
·
02 Apr

BRIEF-Nuvation Bio Enters Supply Agreement With Asymchem For Taletrectinib

Reuters
·
25 Mar

Nuvation Bio Inc - Enters Supply Agreement With Asymchem for Taletrectinib - SEC Filing

THOMSON REUTERS
·
25 Mar

BRIEF-Nuvation Bio to Present Matching-adjusted Indirect Comparison Data for Taletrectinib vs. Crizotinib During Mini Oral Presentation at the European Lung Cancer Congress 2025

Reuters
·
25 Mar